Browsing: Sarfez Pharmaceuticals

Soanz provides a new low-cost treatment option to people suffering from heart failure and chronic kidney disease.

The company gets ‘Notice of Allowance’ from USPTO for its patent application.

FDA, which has accepted the New Drug Application for SoanzXR, is expected to complete review by mid-January.